These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 22425924)
1. NUT rearrangement is uncommon in human thymic epithelial tumors. Petrini P; French CA; Rajan A; Cameron MJ; Jaffe ES; Zucali PA; Xie J; Wang Y; Giaccone G J Thorac Oncol; 2012 Apr; 7(4):744-50. PubMed ID: 22425924 [TBL] [Abstract][Full Text] [Related]
2. [Utility of NUT gene expression and rearrangement in diagnosis of NUT midline carcinoma in upper respiratory tract]. Fang W; French CA; Cameron MJ; Han YD; Liu HG Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):519-24. PubMed ID: 23157742 [TBL] [Abstract][Full Text] [Related]
3. NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract. Stelow EB; Bellizzi AM; Taneja K; Mills SE; Legallo RD; Kutok JL; Aster JC; French CA Am J Surg Pathol; 2008 Jun; 32(6):828-34. PubMed ID: 18391746 [TBL] [Abstract][Full Text] [Related]
4. Pathologic characteristics of NUT midline carcinoma arising in the mediastinum. Evans AG; French CA; Cameron MJ; Fletcher CD; Jackman DM; Lathan CS; Sholl LM Am J Surg Pathol; 2012 Aug; 36(8):1222-7. PubMed ID: 22790861 [TBL] [Abstract][Full Text] [Related]
5. Nuclear protein in testis midline carcinomas: a lethal and underrecognized entity. Davis BN; Karabakhtsian RG; Pettigrew AL; Arnold SM; French CA; Brill YM Arch Pathol Lab Med; 2011 Nov; 135(11):1494-8. PubMed ID: 22032580 [TBL] [Abstract][Full Text] [Related]
6. Demystified molecular pathology of NUT midline carcinomas. French CA J Clin Pathol; 2010 Jun; 63(6):492-6. PubMed ID: 18552174 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance of NUT rearrangements in poorly differentiated malignant tumors of the upper respiratory tract. Fang W; French CA; Cameron MJ; Han Y; Liu H Int J Surg Pathol; 2013 Apr; 21(2):102-10. PubMed ID: 22777717 [TBL] [Abstract][Full Text] [Related]
8. NUT gene rearrangement in a poorly-differentiated carcinoma of the submandibular gland. Ziai J; French CA; Zambrano E Head Neck Pathol; 2010 Jun; 4(2):163-8. PubMed ID: 20352379 [TBL] [Abstract][Full Text] [Related]
9. NUT Carcinoma of the Salivary Glands: Clinicopathologic and Molecular Analysis of 3 Cases and a Survey of NUT Expression in Salivary Gland Carcinomas. Agaimy A; Fonseca I; Martins C; Thway K; Barrette R; Harrington KJ; Hartmann A; French CA; Fisher C Am J Surg Pathol; 2018 Jul; 42(7):877-884. PubMed ID: 29649019 [TBL] [Abstract][Full Text] [Related]
10. Histogenetic and disease-relevant phenotypes in thymic epithelial tumors (TETs): The potential significance for future TET classification. Yamada Y Pathol Int; 2023 Jul; 73(7):265-280. PubMed ID: 37278579 [TBL] [Abstract][Full Text] [Related]
11. NUT midline carcinomas in the thymic region. Gökmen-Polar Y; Cano OD; Kesler KA; Loehrer PJ; Badve S Mod Pathol; 2014 Dec; 27(12):1649-56. PubMed ID: 24851833 [TBL] [Abstract][Full Text] [Related]
12. Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma. Thompson-Wicking K; Francis RW; Stirnweiss A; Ferrari E; Welch MD; Baker E; Murch AR; Gout AM; Carter KW; Charles AK; Phillips MB; Kees UR; Beesley AH Oncogene; 2013 Sep; 32(39):4664-74. PubMed ID: 23128391 [TBL] [Abstract][Full Text] [Related]
13. Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs). Tiseo M; Damato A; Longo L; Barbieri F; Bertolini F; Stefani A; Migaldi M; Gnetti L; Camisa R; Bordi P; Buti S; Rossi G Lung Cancer; 2017 Feb; 104():24-30. PubMed ID: 28212996 [TBL] [Abstract][Full Text] [Related]
14. BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. French CA; Miyoshi I; Kubonishi I; Grier HE; Perez-Atayde AR; Fletcher JA Cancer Res; 2003 Jan; 63(2):304-7. PubMed ID: 12543779 [TBL] [Abstract][Full Text] [Related]
15. Expression of c-Jun, p73, Casp9, and N-ras in thymic epithelial tumors: relationship with the current WHO classification systems. Ma Y; Li Q; Cui W; Miao N; Liu X; Zhang W; Zhang C; Wang J Diagn Pathol; 2012 Sep; 7():120. PubMed ID: 22974165 [TBL] [Abstract][Full Text] [Related]
16. Elevated CRP levels predict poor outcome and tumor recurrence in patients with thymic epithelial tumors: A pro- and retrospective analysis. Janik S; Bekos C; Hacker P; Raunegger T; Ghanim B; Einwallner E; Beer L; Klepetko W; Müllauer L; Ankersmit HJ; Moser B Oncotarget; 2017 Jul; 8(29):47090-47102. PubMed ID: 28514756 [TBL] [Abstract][Full Text] [Related]
17. Assessment of the ITMIG Statement on the WHO Histological Classification and of the Eighth TNM Staging of Thymic Epithelial Tumors of a Series of 188 Thymic Epithelial Tumors. Meurgey A; Girard N; Merveilleux du Vignaux C; Maury JM; Tronc F; Thivolet-Bejui F; Chalabreysse L J Thorac Oncol; 2017 Oct; 12(10):1571-1581. PubMed ID: 28694035 [TBL] [Abstract][Full Text] [Related]
18. Discovery and validation of DNA methylation markers for overall survival prognosis in patients with thymic epithelial tumors. Li S; Yuan Y; Xiao H; Dai J; Ye Y; Zhang Q; Zhang Z; Jiang Y; Luo J; Hu J; Chen C; Wang G Clin Epigenetics; 2019 Mar; 11(1):38. PubMed ID: 30832724 [TBL] [Abstract][Full Text] [Related]
19. Prognostic relevance of programmed cell death protein 1/programmed death-ligand 1 pathway in thymic malignancies with combined immunohistochemical and biomolecular approach. Berardi R; Goteri G; Brunelli A; Pagliaretta S; Paolucci V; Caramanti M; Rinaldi S; Refai M; Pompili C; Morgese F; Torniai M; Marcantognini G; Ricci G; Mazzanti P; Onofri A; Bianchi F; Sabbatini A; Cascinu S Expert Opin Ther Targets; 2020 Sep; 24(9):937-943. PubMed ID: 32662701 [TBL] [Abstract][Full Text] [Related]
20. Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma. Lee JK; Louzada S; An Y; Kim SY; Kim S; Youk J; Park S; Koo SH; Keam B; Jeon YK; Ku JL; Yang F; Kim TM; Ju YS Ann Oncol; 2017 Apr; 28(4):890-897. PubMed ID: 28203693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]